¥ 2563
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Strong margins and returns
About
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents,...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,
Target Price
The average target price of 4543.T is 3170 and suggests 25% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
